Effects of colchicine on the hypothalamo-neurohypophysial system of chronically salt-loaded rats.
The effect of colchicine on the hypothalamo-neurohypophysial system of rats drinking 2% NaCl for 4, 6, or 90 days was investigated. Colchicine was injected at time 0 for the 4-day group and 48 h before sacrifice for the 6- and 90-day groups. Each experimental group was divided into two subgroups that were injected with 7 micrograms colchicine into either the cisterna magna or the lateral cerebral ventricle. The hypothalamo-neurohypophysial system was investigated immunocytochemically using an antiserum against both neurophysins (NPs) as primary antibody. The arginine vasopressin content of the neural lobe (NL) of rats salt loaded for 4 days and injected with colchicine on days 0 and 3 was determined by radioimmunoassay. The amount of immunoreactive NPs in the supraoptic nucleus, the paraventricular nucleus, and in the NL was decreased in salt-loaded rats. In salt-loaded rats injected with colchicine into the lateral ventricle, a substantially larger amount of immunoreactive NPs was present in these three areas. However, when colchicine was injected into the cisterna magna, only the supraoptic nucleus appeared loaded with immunoreactive NPs, while NPs were depleted from the paraventricular nucleus. In the NL of rats salt loaded for 90 days immunoreactive NPs were diminished markedly, and axon swellings (Herring bodies) had virtually disappeared. Colchicine treatment of these rats caused an increase of immunoreactive NPs in the NL approaching control values and a reappearance of a large number of axon swellings. Results similar to those obtained with immunohistochemistry for NPs were obtained when determining the arginine vasopressin content of the NL by radioimmunoassay.(ABSTRACT TRUNCATED AT 250 WORDS)
Peña
P
P
Instituto de Histología y Patología, Universidad Austral de Chile, Valdivia.
Rodríguez
E M
EM
Dellmann
H D
HD
Schoebitz
K
K
D000818:Animals; D001127:Arginine Vasopressin / Q000032:analysis; D003078:Colchicine / Q000494:pharmacology*; D006735:Horseradish Peroxidase; D007030:Hypothalamo-Hypophyseal System / Q000032:analysis / Q000166:cytology / Q000187:drug effects*; D007276:Injections, Intraventricular; D008297:Male; D010286:Paraventricular Hypothalamic Nucleus / Q000032:analysis / Q000166:cytology; D010904:Pituitary Gland, Posterior / Q000032:analysis / Q000166:cytology / Q000187:drug effects*; D011863:Radioimmunoassay; D051381:Rats; D011919:Rats, Inbred Strains; D012982:Sodium, Dietary / Q000494:pharmacology*; D013495:Supraoptic Nucleus / Q000032:analysis / Q000166:cytology
D012982:Sodium, Dietary; D001127:Arginine Vasopressin; D006735:Horseradish Peroxidase; D003078:Colchicine